Estradiol hemihydrate(CAS: 35380-71-3)

Estradiol hemihydrate (CAS: 35380-71-3) is classified as an endocrine disruptor under the Globally Harmonized System of Classification and Labeling of Chemicals (GHS). It falls under REACH regulations in the European Union, requiring registration, evaluation, and authorization. In the United States, it is regulated by the FDA for pharmaceutical purposes and the EPA for environmental protection. Compliance with these regulations is essential for handling and manufacturing this compound.

Estradiol hemihydrate (CAS: 35380-71-3) is often used in pharmaceutical and research applications. Alternatives include other forms of estradiol, such as estradiol benzoate or estradiol valerate. In synthesis, ethinyl estradiol is a common alternative due to its similar chemical structure and properties. These alternatives can be considered based on specific application requirements and regulatory compliance.

The market for Estradiol hemihydrate (CAS: 35380-71-3) is driven by its use in hormone replacement therapy and as a research tool. Recent trends show increasing demand in pharmaceuticals and academic research, particularly in studies related to estrogen metabolism and hormonal imbalance. The global market is expected to grow due to the expanding elderly population and rising healthcare awareness.

Waste containing Estradiol hemihydrate (CAS: 35380-71-3) should be managed according to hazardous waste regulations. Collect waste liquids in appropriate containers, ensuring they are labeled properly. For solid waste, follow local guidelines for disposal. Incineration or professional waste disposal services are recommended to ensure safe and environmentally friendly disposal. Always consult local regulations and safety protocols to handle waste effectively.